In modern surgical oncology, the Sentinel Lymph Node (SLN) biopsy has emerged as a cornerstone for staging various cancers, including melanoma, breast, and gynecological malignancies. The "sentinel" node is defined as the first lymph node or group of nodes that cancer cells are likely to reach after breaking away from a primary tumor. By identifying and analyzing these specific nodes, clinicians can determine the extent of disease spread with high precision while minimizing the physical toll on the patient.
This essay draft explores the significance of biopsy and mapping—a critical procedure used to determine if cancer has spread to the lymphatic system. The Role of SLN Biopsy in Modern Oncology sln-bones 110343:21 Min
Sentinel Lymph Node Biopsy - NCI - National Cancer Institute In modern surgical oncology, the Sentinel Lymph Node